Isosorbid Dinitrat Eipico (Isosorbide Dinitrate)

Isosorbide dinitrate is used in the management of cardiovascular conditions that involve reduced coronary blood flow.

• Angina pectoris: provides rapid relief of chest pain by dilating coronary arteries and reducing cardiac workload.
• Chronic heart failure: improves symptoms and exercise tolerance through venous pooling and decreased preload.
• Prophylaxis of angina attacks: maintains long‑term control of angina frequency when taken regularly.

• Isosorbide dinitrate is metabolized to release nitric oxide (NO) within vascular smooth muscle. NO activates soluble guanylate cyclase, increasing cyclic guanosine monophosphate (cGMP) levels, which leads to relaxation of smooth‑muscle cells. This vasodilatory effect reduces both preload and afterload, decreasing myocardial oxygen consumption and alleviating ischemic chest pain. The resulting venous dilation stores blood in the peripheral circulation, further lowering cardiac filling pressures.

Isosorbide dinitrate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Headache: throbbing pain often occurring shortly after dosing.
• Dizziness or light‑headedness: due to transient blood pressure reduction.
• Flushing: warm sensation and reddening of the skin.
• Hypotension: measurable drop in blood pressure, especially when standing.
• Nausea or vomiting: gastrointestinal discomfort.
• Tachycardia: compensatory increase in heart rate.

Serious or Rare Side Effects

• Severe hypotension: can lead to syncope or shock.
• Reflex tachyarrhythmias: potentially dangerous rapid heart rhythms.
• Myocardial infarction: rare but reported in susceptible patients.
• Allergic reactions: rash, itching, or anaphylaxis.
• Methemoglobinemia: abnormal hemoglobin causing cyanosis.
• Persistent headache unresponsive to therapy.

When prescribing or dispensing isosorbide dinitrate, several precautions should be observed to ensure safe use.

• Dose titration: start with the lowest effective dose and increase gradually under medical supervision.
• Concomitant PDE‑5 inhibitors: avoid using together due to risk of profound hypotension.
• Blood pressure monitoring: check supine and standing pressures regularly.
• Anemia or low hemoglobin: use cautiously as vasodilation may exacerbate symptoms.
• Abrupt discontinuation: taper the dose to prevent rebound angina.
• Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and light.

Isosorbide dinitrate can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): may cause life‑threatening hypotension.
• Other nitrates or nitroglycerin products: additive vasodilatory effect leading to severe blood pressure drop.
• Antihypertensive agents (e.g., ACE inhibitors, beta‑blockers) in high doses: can produce excessive hypotension.
• Alcohol: potentiates vasodilatory action and dizziness.
• Guanylate cyclase stimulators: increase risk of hypotension.

Moderate Interactions (Monitor Closely)

• Diuretics: may enhance blood pressure‑lowering effect; monitor electrolytes.
• Calcium channel blockers: can augment vasodilation; observe for signs of hypotension.
• Beta‑blockers: may mask tachycardia; assess heart rate response.
• Antidiabetic drugs: hypotension may affect glucose control; check blood sugar.
• Certain antibiotics (e.g., macrolides): may affect metabolism; observe for adverse reactions.